期刊文献+

高容量血液滤过治疗重症感染性休克的疗效观察 被引量:4

Curative effect of high volume hemofiltration in the treatment of severe septic shock
下载PDF
导出
摘要 目的探讨高容量血液滤过对重症感染性休克患者的疗效。方法36例重症感染性休克患者随机分为对照组(18例)和治疗组(18例),对照组予以常规治疗,治疗组在常规治疗的基础上加用高容量血液滤过治疗,比较两组患者治疗前后呼吸、血流动力学、血气指标、炎症因子以及APACHEII变化。结果两组患者治疗后呼吸、血气指标、炎症因子以及APACHEII指标均有改善(P〈0.05);治疗组改善更为明显(P〈0.05),且治疗组治疗起效时间明显提前。结论高容量血液滤过能改善重症感染性休克患者呼吸、血流动力学指标,降低动脉血乳酸、炎症介质水平及APACHEII评分,改善患者预后。 Objective To observe the efficacy of high volume hemofihration (HVHF) in the treatment of severe septic shock. Methods A total of 36 patients with severe septic shock were divided into treatment group and control group (n= 18 each). All patients received volume resuscitation, vasopressor drug, early antibiotic administration, and other treatments. Patients in the treatment group received HVHF for 72 h simultaneously. Results The parameters of respiratory and hemodynamic function, the blood gas analysis, systemic inflammation and APACHE II were improved after the treatment in two groups (P 〈0.05). Compared with the control group, the levels of above parameters were significantly improved in the treatment group (P 〈0.05). In addition, the initial effective time of the treatment group was significantly earlier. Conclusion HVHF can significantly improve the prognosis of patients with severe septic shock through alleviating respiratory-circulation failure, reducing blood lactic acid and systemic inflammation as well as APACHEII scores.
出处 《中国急救复苏与灾害医学杂志》 2015年第11期1072-1076,共5页 China Journal of Emergency Resuscitation and Disaster Medicine
关键词 高容量血液滤过 重症感染性休克 炎症介质 High volume hemofiltration Severe septic shock Inflammation mediators
  • 相关文献

参考文献24

  • 1Angus DC,Linde-Zwirble WT,Lidicker J,et al.Epidemiology of sev- ere sepsis in the United States: Analysis of incidence, outcome, and associated costs of care [J].Crit Care Med,2001,29(7):1303-1310.
  • 2Dellinger RP,Levy M,Carlet JM,et al.Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008 [J]. Intensive Care Med,2008,34(1):17-60.
  • 3Dellinger RP,Levy MM,Rhodes A,et al.paigu:international guidelines for management of severe sepsis and septic shock,2012[J].Intensive Care Med,2013,39(2): 165-228.
  • 4姜利.持续性肾脏替代治疗的药物剂量调整[J].中国实用内科杂志,2012,32(6):426-428. 被引量:6
  • 5黄英姿,邱海波.连续血液滤过时药物剂量的调整[J].中国实用外科杂志,2008,28(6):445-448. 被引量:4
  • 6Marshall JC. SIRS and MODS: what is their relevance to the science and practice of intensive care[J].Shock,2000,14(6):586-589.
  • 7Brunet S,Leblanc M,Geadah D,et al.Diffusive and convective solute clearances during continuous renal replacement therapy at various dialysate and ultrafiltration flow rates [J]. Am J Kidney Dis,1999,34 (3):486-492.
  • 8Hofmann CL, Fissell WH.Middle-molecule clearance at 20 and 35 ml/kg/h in continuous venovenous hemodiafiltration [J]. Blood Purl f,2010,29(3):259-263.
  • 9RENAL Replacement Therapy Study Investigators, Bellomo R, Cass A, et al.lntensity of continuous renal-replacement therapy in critic- ally ill patients [J].N Engl J Med,2009,361(17):1627-1638.
  • 10李莉,史伟,陈铁锋,刘双信.间歇性高容量血液滤过对肾替代治疗病人血清莫西沙星药物浓度的影响[J].中国病理生理杂志,2011,27(5):1008-1011. 被引量:5

二级参考文献53

共引文献43

同被引文献29

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部